Convertible Completed
Apimeds Pharmaceuticals US equity raising
US$10.9m raised
Announced 1 Dec 2025 · NYSE AMERICAN: APUS
Advisers
Lead managers
- Placement agent
- EF Hutton (as E.F. Hutton & Co.)
- Issuer
- Apimeds Pharmaceuticals US
- Issuer based in
- United States
- Completed
- 27 Feb 2026
- Sector
- Pharma
- Tags
- Pharma, Biotech
Similar deals
- Optimi Health Corp. equity raising May 2026 · US$15m · Biotech
- Quince Therapeutics placement May 2026 · US$115m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Seaport Therapeutics IPO Apr 2026 · US$255m · Biotech
- Veradermics IPO Feb 2026 · US$256m · Dermatology